Kiarash Khosrotehrani — ASN Events

Kiarash Khosrotehrani

University of Queensland, QLD, Australia

  • This delegate is presenting an abstract at this event.
Prof Khosrotehrani obtained his MD in Paris, France, where he specialized in Dermatology. He is a former graduate of the Ecole Normale Supérieure and the Institut Pasteur of Paris (Université Paris VI, Pierre et Marie Curie) where he obtained a PhD in Physiology and Physiopathology. He completed his post-doctoral training in stem cell biology and clinical genetics at Tufts-New England Medical Centre in Boston, USA. He is a fellow of the Australian College of Dermatologists and the director of Dermatology at the Princess Alexandra Hospital. He is the co-director of the Australian Skin and Skin Cancer Research Centre. He is the immediate-past president of the Australasian Society for Dermatology Research, a board director of the Australasian College of Dermatologists and the Queensland Skin and Cancer Foundation. His research is fundamentally based on regenerative medicine concepts applied at basic, translational and clinical levels to melanoma, keratinocyte cancers and skin wounds.
Presentations this author is a contributor to:

Diagnostic performance of neural networks in dermoscopic assessment of melanocytic lesions: context is critical. (#115)

2:18 PM
Nicholas M Muller
Session 11.3 - AI and Technology

Association between body mass index and melanoma prognosis in patients with high-risk primaries. (#87)

12:10 PM
Hansa Sharma
Session 10.1 - Epidemiology, Burden, Risk

The burning question – how safe is sun exposure at low dose and intensity? (#159)

12:30 PM
Montana O'Hara
Poster Session (6iCUSP & 5GAC-SC)

Trends Of Skin CAncer Numbers In solid organ transplant recipients, the TOSCANI cohort study (#210)

12:20 PM
Anne Tseng
Session 14.1 - Organ Transplant Recipients

Chronic UVB exposure induces early transcriptomic changes associated with skin cancer development (#227)

2:50 PM
Chenhao Zhou
Session 15.2 - Spatial Omics

Association between social advantage and melanoma stage at diagnosis (#86)

12:00 PM
Danielle Gavanescu
Session 10.1 - Epidemiology, Burden, Risk

Unravelling transcriptomics effects of sirolimus in cutaneous squamous cell carcinomas chemoprevention (#226)

2:40 PM
Lea Dousset
Session 15.2 - Spatial Omics

Immune checkpoint inhibitors impact skin field cancerisation by reducing actinic keratoses and keratinocyte carcinomas (#121)

4:45 PM
Charlotte Cox
Joint Plenary Session 12.0

Epidermal Carcinoma Development in Organ-Transplanted Recipients: Epidermal Cell Dynamic Analysis in Response to Cyclosporine A Treatment (#215)

11:20 AM
Edwige Roy
Session 14.3 - Biology